Assignee
DILAFOR AB
SE·5 granted patents·5 pending applications·2 citations·filing 2003–2025
Top patents by PatentIndex Score
10 records- 0165US2023355658A1Medical use of tafoxiparinDILAFOR AB·Filed 2023·Application pending·0 cites
- 0265US2025360160A1New medical use of tafoxiparinDILAFOR AB·Filed 2023·Application pending·0 cites
- 0363US12419904B2Medical use of tafoxiparinDILAFOR AB·Filed 2025·Granted Sep 23, 2025·0 cites·30 claims
- 0460US7407945B2Use of sulfated glycosaminoglycans for establishing effective labor in womenDILAFOR AB·Filed 2003·Granted Aug 5, 2008·2 cites·11 claims
- 0555US12502403B2Tafoxiparin for the treatment of preeclampsiaDILAFOR AB·Filed 2021·Granted Dec 23, 2025·0 cites·20 claims
- 0643US2015057226A1Method for treatment of labor arrestDILAFOR AB·Filed 2013·Application pending·0 cites
- 0737US10023659B2Processes for the production of chemically-modified heparinsDILAFOR AB·Filed 2014·Granted Jul 17, 2018·0 cites·17 claims
- 0836US2015045322A1Combination treatment comprising sulphated glycosaminoglycans for inducing laborDILAFOR AB·Filed 2013·Application pending·0 cites
- 0936US2015099703A1Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agentDILAFOR AB·Filed 2013·Application pending·0 cites
- 1035US9475888B2Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical useDILAFOR AB·Filed 2012·Granted Oct 25, 2016·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when DILAFOR AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →